z-logo
open-access-imgOpen Access
Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy
Author(s) -
Mark Riley,
Paul Der Mesropian,
Ana Maheshwari,
Mustafa Erdem Arslan,
Parth Visrodia,
Loay Salman,
Ruben Peredo-Wende,
Llewellyn Foulke,
Krishnakumar Hongalgi
Publication year - 2022
Publication title -
journal of investigative medicine high impact case reports
Language(s) - English
Resource type - Journals
ISSN - 2324-7096
DOI - 10.1177/23247096221074591
Subject(s) - medicine , thrombotic microangiopathy , microangiopathic hemolytic anemia , monoclonal gammopathy of undetermined significance , paraproteinemia , renal biopsy , microangiopathy , plasma cell dyscrasia , dermatology , pathology , multiple myeloma , biopsy , immunology , monoclonal , thrombotic thrombocytopenic purpura , monoclonal antibody , antibody , platelet , disease , immunoglobulin light chain , endocrinology , diabetes mellitus
Systemic sclerosis with negative serology, particularly that complicated by scleroderma renal crisis (SRC), is rarely encountered. We describe a patient with seronegative systemic sclerosis who developed acute kidney injury, proteinuria, and hypertensive emergency following motor vehicle-related trauma and in the setting of nonsteroidal anti-inflammatory drug use. Findings on physical examination, imaging, and skin biopsy led to a clinical diagnosis of scleroderma, despite the lack of supportive laboratory data. IgG lambda paraproteinemia was detected on workup. Bone marrow biopsy showed plasmacytosis and trace lambda-restricted plasma cells consistent with monoclonal gammopathy of undetermined significance. Chemotherapy was initially started given concern for myeloma with cast nephropathy but was later stopped after a kidney biopsy revealed thrombotic microangiopathy (TMA). The SRC associated with TMA was ultimately diagnosed, though atypical hemolytic uremic syndrome (aHUS) induced perhaps by monoclonal gammopathy or hypertension was also possible. Captopril and eculizumab were initiated for SRC and aHUS, respectively. Despite therapy, renal function did not recover, and the patient required hemodialysis indefinitely. This case highlights clinical features common to both SRC and aHUS as well as points out a few ways to differentiate between them.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom